Back to Agenda
Opening Plenary and Keynote Address
Session Chair(s)
Marwan Fathallah, MBA, MSC
President & Chief Executive Officer, DIA, United States
Join our opening plenary session, Innovation: The Possibilities, The Boundaries: Charting New Horizons, led by Tom and Emily Whitehead, who will give the incredible journey of Emily Whitehead, the pioneering pediatric patient who defied the odds and became the first in the world to undergo CAR T-cell therapy. Tom and Emily will share their invaluable insights into the transformative power of CAR-T therapy, offering a unique perspective that promises to captivate and inspire. Dean Kamen will discuss the Future of Regenerative Therapies, How Public-Private Partnerships Can Impact Advancement. Following your keynotes, we will have a panel discussion. Attendees can expect a lively and engaging discussion, with a diverse range of perspectives and insights from panelists who are leaders and at the forefront of our industry; including panelists from the Gates Foundation, regulatory agencies, and the patient perspective.
Speaker(s)
Developing Cell Therapies for Cancer Patients
Chief Executive Officer, Neogene Therapeutics, AstraZeneca Group, Netherlands
Keynote Speaker: Insights into the Transformative Power of CAR-T Therapy
Co-Founder and President, Emily Whitehead Foundation, United States
Keynote Speaker: Insights into the Transformative Power of CAR-T Therapy
Co-Founder, Emily Whitehead Foundation, United States
Keynote Speaker: Future of Regenerative Therapies - How Public-Private Partnerships Can Impact Advancement
Founder , DEKA Research & Development Corp., United States
Plenary Panel: Innovation - The Possibilities, the Boundaries - Charting New Horizons
Deputy Director, Africa Regulatory Systems, Bill & Melinda Gates Foundation, United States
Panelist: Innovation
Founder , DEKA Research & Development Corp., United States
Panelist: EMA Perspective
Chair, ICMRA; Executive Director, European Medicines Agency, Netherlands
Panelist: FDA Perspective
Senior Vice President, Molecule Discovery and Head of Infectious Disease, Eli Lilly and Company, United States
Panelist: Patient Perspective
Chief Patient Officer, Parexel, United States
Have an account?